The 2019 USP <797> & <800> Compliance Study


a National Study of Sterile Compounding Practices

Study Directors : Eric S Kastango, RPh, MBA, FASHP Kate Douglass, MS, RN, QP503A qualified





Welcome to
2019 USP <797>&<800> Compliance Study


a National Study of Hazardous Drug Compounding Practices


The 2019 CriticalPoint USP <797> & <800> Compliance Study Results report have been published. To read the full reports click here for both the <797> & <800> reports

We would like to thank everyone that participated in this year’s Study. We would also like to thank our sponsors and supporters for helping to make the Study a success.

To use the Gap Analysis Tool (based on the current standards) during the closed Study time you can click on the Register button below and use the Survey Code J797Z   

***In August 2019 we will be updating the entire Compliance Tool which will be based on the newly published standards that will become offical December 1, 2019.***

If you have an active account you can continue to access your survey by logging into the site below with your username and password and make updates to your survey until we begin the 2019 Compliance Study in the Fall 2019.

Before you begin your study, we encourage to read the How To Use the Study Tool, view a Sample Report or access to your prior Gap Analysis (if applicable) once you login to your account.

If you have questions or need any assistance, please contact the Study Team at 973-256-6500 or via email at

Log In
To begin, click the Register link below.


Thank you again for your participation in the 2019 USP <797>&<800> Compliance Study.

Study Directors